Gender-specific 99th percentiles for hs-cTnT were 16.8 ng/L in males and 13.1 ng/L in females, whereas hs-cTnI showed larger differences (29.7 ng/L in males vs 10.3 ng/L in females).
Observational (n=827)
In a well-phenotyped healthy cohort, gender differences were more pronounced for hs-cTnI than hs-cTnT, and hs-cTnT fulfilled high-sensitivity designation criteria for both genders whereas hs-cTnI did not for females.
To determine gender-specific reference limits of high-sensitivity (hs) cardiac troponins (cTn) and validity of hs assay designation for both genders. After screening with a questionnaire, 827 presumably healthy individuals were further selected based on clinical criteria (n = 740), clinical criteria plus cardiac imaging including stress magnetic resonance imaging or stress echocardiography (n = 726), and extended cardio-pulmonary parameters (n = 626). Blood samples were measured with hs-cTnT (Roche Diagnostics) on a cobas e602 analyzer as well as hs-cTnI (Abbott Diagnostics) on an ARCHITECTi2000SR. The impact of health definition, statistical methods, instrument selection and limit of detection (LoD) on overall and gender-specific 99th percentiles was assessed. Median age was 56 years (50.9% female) for the total study cohort. 99th percentiles for females and males ranged between 13.1 and 13.3 ng/L and 16.8–19.9 ng/L for hs-cTnT as well as 10.3–12.5 ng/L and 27.4–29.7 ng/L for hs-cTnI depending on health definition. Utilization of stricter health definition criteria reduced the difference of the gender-specific 99th percentiles between males and females for hs-cTnT to 3.7 ng/L (males 16.8 ng/L, females 13.1 ng/L), whereas the difference rather increased for hs-cTnI to 19.4 ng/L (males 29.7 ng/L, females 10.3 ng/L). Values > LoD could be measured in the majority of males and females using hs-TnT (81.4–83.3% and 96.5–96.9%, respectively). In contrast, values > LoD could not be observed in the majority of females using hs-cTnI (38.4–41.1%). In a well-phenotyped healthy cohort, reference values for hs-cTnT were slightly higher, whereas hs-cTnI cut-offs were considerably lower than previously observed. Gender differences were more pronounced in hs-cTnI than in hs-cTnT and were further reduced for hs-cTnT by application of stricter health definition criteria. Contrary to hs-cTnI, hs-cTnT fulfilled criteria for hs designation for both genders.
Giannitsis et al. (Thu,) conducted a observational in Healthy individuals (n=827). High-sensitivity cardiac troponin T and I assays was evaluated on Gender-specific 99th percentiles of hs-cTnT and hs-cTnI. Gender-specific 99th percentiles for hs-cTnT were 16.8 ng/L in males and 13.1 ng/L in females, whereas hs-cTnI showed larger differences (29.7 ng/L in males vs 10.3 ng/L in females).